The incomplete inhibition of chemotaxis towards C5a may also prove to be of higher clinical utility than complete blockade in order to dampen inflammation but preserve complement peptide action in the innate immune response and minimise the risk of bacterial infection [48]. This evidence concerns the gene C5AR1 and bacterial infectious disease.